What is the recommended starting dose of metoprolol (immediate‑release tartrate and extended‑release succinate)?

Metoprolol Starting Dose Recommendations

For heart failure with reduced ejection fraction (HFrEF), start metoprolol succinate extended-release at 12.5–25 mg once daily; for hypertension, start metoprolol tartrate at 25–50 mg twice daily or metoprolol succinate at 50 mg once daily. 1, 2

---

Heart Failure with Reduced Ejection Fraction (HFrEF)

Formulation-Specific Requirement

• Only metoprolol succinate extended-release (CR/XL) has proven mortality reduction in heart failure—metoprolol tartrate (immediate-release) should never be used for this indication. 1, 3
• The MERIT-HF trial demonstrated a 34% reduction in all-cause mortality, 38% decrease in cardiovascular mortality, and 41% reduction in sudden death using metoprolol succinate. 1

Starting Dose

• Begin with 12.5 mg once daily in patients with NYHA class III–IV heart failure or those at higher risk of decompensation. 1, 3
• Begin with 25 mg once daily in patients with NYHA class II heart failure who are clinically stable. 1, 3

Titration Protocol

• Double the dose every 2 weeks if the preceding dose is well tolerated, following the progression: 12.5 mg → 25 mg → 50 mg → 100 mg → 200 mg once daily. 1, 3
• The target dose is 200 mg once daily, which was the dose used in the MERIT-HF trial that demonstrated mortality benefit. 1, 3
• If the full target cannot be achieved, aim for at least 50% of target dose (100 mg daily minimum), as dose-response relationships exist for mortality benefit. 1

Absolute Contraindications Before Initiation

• Current or recent (within 4 weeks) decompensated heart failure requiring hospitalization. 1
• Signs of heart failure exacerbation: pulmonary rales, peripheral edema, acute dyspnea, or low cardiac output state. 1, 4
• Systolic blood pressure <100 mmHg with symptoms. 1
• Heart rate <50 bpm or >110 bpm. 1, 4
• PR interval >0.24 seconds, second- or third-degree AV block without a functioning pacemaker. 1, 4
• Active asthma or severe reactive airway disease with current bronchospasm. 1, 4

---

Hypertension

Formulation Options

• Metoprolol tartrate (immediate-release): Start at 25–50 mg twice daily, with a maximum of 200 mg twice daily. 1, 2
• Metoprolol succinate (extended-release): Start at 50 mg once daily, with a maximum of 400 mg once daily. 1, 2, 3

Important Clinical Context

• Beta-blockers are not first-line agents for uncomplicated hypertension unless the patient has a compelling indication such as ischemic heart disease, heart failure, or atrial fibrillation. 1, 3
• First-line agents are ACE inhibitors, ARBs, dihydropyridine calcium-channel blockers, and thiazide diuretics. 3

Titration

• Increase the dose every 1–2 weeks based on blood pressure response, targeting <130/80 mmHg. 1, 2

---

Post-Myocardial Infarction

Early IV Phase (Acute Setting)

• Administer 5 mg IV bolus over 1–2 minutes, repeated every 5 minutes for up to 3 doses (maximum 15 mg total) in hemodynamically stable patients. 1, 4
• This should only be done in a coronary care unit with continuous monitoring of blood pressure, heart rate, and ECG. 4

Transition to Oral Therapy

• Begin metoprolol tartrate 50 mg every 6 hours starting 15 minutes after the last IV dose, continued for 48 hours. 1, 4
• In patients who do not tolerate the full IV dose, start with 25 mg every 6 hours instead. 4

Long-Term Maintenance

• Transition to metoprolol succinate 200 mg once daily for secondary prevention, titrated gradually over 2–3 weeks. 1

Critical Contraindications to IV Metoprolol in Acute MI

• The COMMIT trial showed that early IV metoprolol increased cardiogenic shock by 11 per 1,000 patients, particularly in high-risk patients. 1, 2
• High-risk features include: age >70 years, systolic BP <120 mmHg, heart rate >110 bpm or <60 bpm, Killip class II–III, or prolonged time since symptom onset. 1, 2, 4

---

Atrial Fibrillation Rate Control

Starting Dose

• Metoprolol tartrate 25–50 mg twice daily or metoprolol succinate 50 mg once daily. 1, 2
• Titrate to a maximum of 100–200 mg twice daily (tartrate) or 50–400 mg once daily (succinate) based on heart rate response. 1, 2

Target Heart Rate

• Lenient control: resting heart rate <110 bpm. 1, 2
• Strict control: resting heart rate 50–80 bpm. 1, 2

IV Dosing for Acute Rate Control

• 5 mg IV bolus over 1–2 minutes, repeated every 5 minutes as needed, with a maximum total dose of 15 mg. 1, 2
• Contraindicated in pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome), as beta-blockade can accelerate ventricular response. 1, 2

---

Special Populations

Elderly Patients (≥65 years)

• Start with the lowest recommended dose (12.5 mg once daily for heart failure, 25 mg twice daily for hypertension) due to greater frequency of decreased hepatic, renal, or cardiac function. 1, 4
• Extend titration intervals to up to 4 weeks if transient side effects develop. 1

Hepatic Impairment

• Metoprolol blood levels increase substantially in hepatic impairment. 4
• Initiate at low doses with cautious gradual titration according to clinical response. 4

Renal Impairment

• No dose adjustment is required in renal impairment. 4

---

Monitoring During Initiation and Titration

At Each Visit (1–2 Weeks After Dose Increase)

• Heart rate: Target 50–60 bpm; reduce dose if <50 bpm with worsening symptoms. 1
• Blood pressure: Asymptomatic hypotension does not require adjustment; symptomatic hypotension (systolic <100 mmHg with dizziness) mandates intervention. 1
• Signs of congestion: Daily weight, peripheral edema, dyspnea; advise increasing diuretic if weight rises 1.5–2.0 kg over 2 consecutive days. 1
• Clinical status: Assess for worsening heart failure symptoms, fatigue, or bronchospasm. 1

---

Common Pitfalls to Avoid

• Never use metoprolol tartrate for heart failure—only metoprolol succinate has proven mortality benefit. 1, 3
• Never abruptly discontinue metoprolol, as this can precipitate severe angina, myocardial infarction, ventricular arrhythmias, and a 2.7-fold increase in 1-year mortality. 1, 2
• Do not initiate in decompensated heart failure—wait until the patient is clinically stable (typically after ~4 days). 1, 4
• Do not give IV metoprolol in acute MI to high-risk patients (age >70, systolic BP <120 mmHg, heart rate >110 or <60 bpm, Killip class >1), as this significantly increases cardiogenic shock risk. 1, 2
• Underdosing is the most common error—fewer than 25% of patients in real-world settings are titrated to target doses, compared to 64% in clinical trials. 1